AMIDE DERIVATIVE HAVING ANTIVIRAL ACTIVITY
The present invention provides: a compound, or a pharmaceutically acceptable salt thereof, having an antiviral activity and represented by formula (I); and a pharmaceutical composition containing the same. (In the formula, the broken lines indicate the presence or absence of bonding; R1 is a carboxy...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | NODU Kouhei AKAZA Hiroto TATENO Yusuke MATOYAMA Masaaki AKIYAMA Toshiyuki FUKUDA Takashi SUZUKI Shinji OKANO Azusa |
description | The present invention provides: a compound, or a pharmaceutically acceptable salt thereof, having an antiviral activity and represented by formula (I); and a pharmaceutical composition containing the same. (In the formula, the broken lines indicate the presence or absence of bonding; R1 is a carboxy or the like; L is a substituted or unsubstituted non-aromatic carbocyclic diyl or the like; R2 is a substituted or unsubstituted alkyl; R3 is a hydrogen atom or the like; X is =CRXâ¿¿ or =Nâ¿¿; Y is =CRYâ¿¿ or =Nâ¿¿; U is â¿¿CRU= or â¿¿N=; V is â¿¿CRV= or â¿¿N=; W is =CRWâ¿¿ or =Nâ¿¿; ZA is â¿¿C= or â¿¿Nâ¿¿; ZB is â¿¿CR5R6â¿¿ or the like; ZC is â¿¿CR7R8â¿¿ or the like; RX, RY, RV and RW are each independently a hydrogen atom or the like; RU is a hydrogen atom or the like; R5 and R6 are each independently a hydrogen atom or the like; R7 and R8 are each independently a hydrogen atom or the like; R4 is substituted or unsubstituted alkyloxy or the like.).
La presente invención proporciona un compuesto representado por la fórmula (I): (ver Fórmula) en donde la línea discontinua indica la presencia o ausencia de un enlace; R1 es carboxi o similar; L es carbociclildiilo no aromático sustituido o no sustituido o similar; R2 es alquilo sustituido o no sustituido; R3 es un átomo de hidrógeno o similar; X es =CRX- o =N-; Y es =CRY- o =N-; U es -CRU= o -N=; V es -CRV= o -N=; W es =CRW- o =N-; ZA es -C= o -N-; ZB es -CR5R6- o similar; ZC es -CR7R8- o similar; RX, RY, RV y RW son cada uno independientemente un átomo de hidrógeno o similar; RU es un átomo de hidrógeno o similar; cada uno de R5 y R6 es independientemente un átomo de hidrógeno o similar; cada uno de R7 y R8 es independientemente un átomo de hidrógeno o similar; R4 es alquiloxi sustituido o no sustituido o similar, o una sal farmacéuticamente aceptable del mismo, que tiene actividad antiviral; y una composición farmacéutica que comprende el mismo. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2023004779A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2023004779A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2023004779A3</originalsourceid><addsrcrecordid>eNrjZNBy9PV0cVVwcQ3yDHMM8QxzVfBwDPP0c1dw9APyPIMcfRQcnUGskEgeBta0xJziVF4ozc2g5OYa4uyhm1qQH59aXJCYnJqXWhLvG2FkYGRsYGBibm7paEyUIgCg7SVG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AMIDE DERIVATIVE HAVING ANTIVIRAL ACTIVITY</title><source>esp@cenet</source><creator>NODU Kouhei ; AKAZA Hiroto ; TATENO Yusuke ; MATOYAMA Masaaki ; AKIYAMA Toshiyuki ; FUKUDA Takashi ; SUZUKI Shinji ; OKANO Azusa</creator><creatorcontrib>NODU Kouhei ; AKAZA Hiroto ; TATENO Yusuke ; MATOYAMA Masaaki ; AKIYAMA Toshiyuki ; FUKUDA Takashi ; SUZUKI Shinji ; OKANO Azusa</creatorcontrib><description>The present invention provides: a compound, or a pharmaceutically acceptable salt thereof, having an antiviral activity and represented by formula (I); and a pharmaceutical composition containing the same. (In the formula, the broken lines indicate the presence or absence of bonding; R1 is a carboxy or the like; L is a substituted or unsubstituted non-aromatic carbocyclic diyl or the like; R2 is a substituted or unsubstituted alkyl; R3 is a hydrogen atom or the like; X is =CRXâ¿¿ or =Nâ¿¿; Y is =CRYâ¿¿ or =Nâ¿¿; U is â¿¿CRU= or â¿¿N=; V is â¿¿CRV= or â¿¿N=; W is =CRWâ¿¿ or =Nâ¿¿; ZA is â¿¿C= or â¿¿Nâ¿¿; ZB is â¿¿CR5R6â¿¿ or the like; ZC is â¿¿CR7R8â¿¿ or the like; RX, RY, RV and RW are each independently a hydrogen atom or the like; RU is a hydrogen atom or the like; R5 and R6 are each independently a hydrogen atom or the like; R7 and R8 are each independently a hydrogen atom or the like; R4 is substituted or unsubstituted alkyloxy or the like.).
La presente invención proporciona un compuesto representado por la fórmula (I): (ver Fórmula) en donde la línea discontinua indica la presencia o ausencia de un enlace; R1 es carboxi o similar; L es carbociclildiilo no aromático sustituido o no sustituido o similar; R2 es alquilo sustituido o no sustituido; R3 es un átomo de hidrógeno o similar; X es =CRX- o =N-; Y es =CRY- o =N-; U es -CRU= o -N=; V es -CRV= o -N=; W es =CRW- o =N-; ZA es -C= o -N-; ZB es -CR5R6- o similar; ZC es -CR7R8- o similar; RX, RY, RV y RW son cada uno independientemente un átomo de hidrógeno o similar; RU es un átomo de hidrógeno o similar; cada uno de R5 y R6 es independientemente un átomo de hidrógeno o similar; cada uno de R7 y R8 es independientemente un átomo de hidrógeno o similar; R4 es alquiloxi sustituido o no sustituido o similar, o una sal farmacéuticamente aceptable del mismo, que tiene actividad antiviral; y una composición farmacéutica que comprende el mismo.</description><language>eng ; spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230509&DB=EPODOC&CC=MX&NR=2023004779A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230509&DB=EPODOC&CC=MX&NR=2023004779A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NODU Kouhei</creatorcontrib><creatorcontrib>AKAZA Hiroto</creatorcontrib><creatorcontrib>TATENO Yusuke</creatorcontrib><creatorcontrib>MATOYAMA Masaaki</creatorcontrib><creatorcontrib>AKIYAMA Toshiyuki</creatorcontrib><creatorcontrib>FUKUDA Takashi</creatorcontrib><creatorcontrib>SUZUKI Shinji</creatorcontrib><creatorcontrib>OKANO Azusa</creatorcontrib><title>AMIDE DERIVATIVE HAVING ANTIVIRAL ACTIVITY</title><description>The present invention provides: a compound, or a pharmaceutically acceptable salt thereof, having an antiviral activity and represented by formula (I); and a pharmaceutical composition containing the same. (In the formula, the broken lines indicate the presence or absence of bonding; R1 is a carboxy or the like; L is a substituted or unsubstituted non-aromatic carbocyclic diyl or the like; R2 is a substituted or unsubstituted alkyl; R3 is a hydrogen atom or the like; X is =CRXâ¿¿ or =Nâ¿¿; Y is =CRYâ¿¿ or =Nâ¿¿; U is â¿¿CRU= or â¿¿N=; V is â¿¿CRV= or â¿¿N=; W is =CRWâ¿¿ or =Nâ¿¿; ZA is â¿¿C= or â¿¿Nâ¿¿; ZB is â¿¿CR5R6â¿¿ or the like; ZC is â¿¿CR7R8â¿¿ or the like; RX, RY, RV and RW are each independently a hydrogen atom or the like; RU is a hydrogen atom or the like; R5 and R6 are each independently a hydrogen atom or the like; R7 and R8 are each independently a hydrogen atom or the like; R4 is substituted or unsubstituted alkyloxy or the like.).
La presente invención proporciona un compuesto representado por la fórmula (I): (ver Fórmula) en donde la línea discontinua indica la presencia o ausencia de un enlace; R1 es carboxi o similar; L es carbociclildiilo no aromático sustituido o no sustituido o similar; R2 es alquilo sustituido o no sustituido; R3 es un átomo de hidrógeno o similar; X es =CRX- o =N-; Y es =CRY- o =N-; U es -CRU= o -N=; V es -CRV= o -N=; W es =CRW- o =N-; ZA es -C= o -N-; ZB es -CR5R6- o similar; ZC es -CR7R8- o similar; RX, RY, RV y RW son cada uno independientemente un átomo de hidrógeno o similar; RU es un átomo de hidrógeno o similar; cada uno de R5 y R6 es independientemente un átomo de hidrógeno o similar; cada uno de R7 y R8 es independientemente un átomo de hidrógeno o similar; R4 es alquiloxi sustituido o no sustituido o similar, o una sal farmacéuticamente aceptable del mismo, que tiene actividad antiviral; y una composición farmacéutica que comprende el mismo.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBy9PV0cVVwcQ3yDHMM8QxzVfBwDPP0c1dw9APyPIMcfRQcnUGskEgeBta0xJziVF4ozc2g5OYa4uyhm1qQH59aXJCYnJqXWhLvG2FkYGRsYGBibm7paEyUIgCg7SVG</recordid><startdate>20230509</startdate><enddate>20230509</enddate><creator>NODU Kouhei</creator><creator>AKAZA Hiroto</creator><creator>TATENO Yusuke</creator><creator>MATOYAMA Masaaki</creator><creator>AKIYAMA Toshiyuki</creator><creator>FUKUDA Takashi</creator><creator>SUZUKI Shinji</creator><creator>OKANO Azusa</creator><scope>EVB</scope></search><sort><creationdate>20230509</creationdate><title>AMIDE DERIVATIVE HAVING ANTIVIRAL ACTIVITY</title><author>NODU Kouhei ; AKAZA Hiroto ; TATENO Yusuke ; MATOYAMA Masaaki ; AKIYAMA Toshiyuki ; FUKUDA Takashi ; SUZUKI Shinji ; OKANO Azusa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2023004779A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>NODU Kouhei</creatorcontrib><creatorcontrib>AKAZA Hiroto</creatorcontrib><creatorcontrib>TATENO Yusuke</creatorcontrib><creatorcontrib>MATOYAMA Masaaki</creatorcontrib><creatorcontrib>AKIYAMA Toshiyuki</creatorcontrib><creatorcontrib>FUKUDA Takashi</creatorcontrib><creatorcontrib>SUZUKI Shinji</creatorcontrib><creatorcontrib>OKANO Azusa</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NODU Kouhei</au><au>AKAZA Hiroto</au><au>TATENO Yusuke</au><au>MATOYAMA Masaaki</au><au>AKIYAMA Toshiyuki</au><au>FUKUDA Takashi</au><au>SUZUKI Shinji</au><au>OKANO Azusa</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AMIDE DERIVATIVE HAVING ANTIVIRAL ACTIVITY</title><date>2023-05-09</date><risdate>2023</risdate><abstract>The present invention provides: a compound, or a pharmaceutically acceptable salt thereof, having an antiviral activity and represented by formula (I); and a pharmaceutical composition containing the same. (In the formula, the broken lines indicate the presence or absence of bonding; R1 is a carboxy or the like; L is a substituted or unsubstituted non-aromatic carbocyclic diyl or the like; R2 is a substituted or unsubstituted alkyl; R3 is a hydrogen atom or the like; X is =CRXâ¿¿ or =Nâ¿¿; Y is =CRYâ¿¿ or =Nâ¿¿; U is â¿¿CRU= or â¿¿N=; V is â¿¿CRV= or â¿¿N=; W is =CRWâ¿¿ or =Nâ¿¿; ZA is â¿¿C= or â¿¿Nâ¿¿; ZB is â¿¿CR5R6â¿¿ or the like; ZC is â¿¿CR7R8â¿¿ or the like; RX, RY, RV and RW are each independently a hydrogen atom or the like; RU is a hydrogen atom or the like; R5 and R6 are each independently a hydrogen atom or the like; R7 and R8 are each independently a hydrogen atom or the like; R4 is substituted or unsubstituted alkyloxy or the like.).
La presente invención proporciona un compuesto representado por la fórmula (I): (ver Fórmula) en donde la línea discontinua indica la presencia o ausencia de un enlace; R1 es carboxi o similar; L es carbociclildiilo no aromático sustituido o no sustituido o similar; R2 es alquilo sustituido o no sustituido; R3 es un átomo de hidrógeno o similar; X es =CRX- o =N-; Y es =CRY- o =N-; U es -CRU= o -N=; V es -CRV= o -N=; W es =CRW- o =N-; ZA es -C= o -N-; ZB es -CR5R6- o similar; ZC es -CR7R8- o similar; RX, RY, RV y RW son cada uno independientemente un átomo de hidrógeno o similar; RU es un átomo de hidrógeno o similar; cada uno de R5 y R6 es independientemente un átomo de hidrógeno o similar; cada uno de R7 y R8 es independientemente un átomo de hidrógeno o similar; R4 es alquiloxi sustituido o no sustituido o similar, o una sal farmacéuticamente aceptable del mismo, que tiene actividad antiviral; y una composición farmacéutica que comprende el mismo.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; spa |
recordid | cdi_epo_espacenet_MX2023004779A |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | AMIDE DERIVATIVE HAVING ANTIVIRAL ACTIVITY |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T23%3A53%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NODU%20Kouhei&rft.date=2023-05-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2023004779A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |